Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones

Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology

Volumn 286, Issue 2, 2005, Pages 945-954

  Nicolin, Vanessa ^a   Ponti, Cristina ^a   Narducci, Paola ^a   Grill, Vittorio ^a   Bortul, Roberta ^a   Zweyer, Marina ^a   Vaccarezza, Mauro ^b   Zauli, Giorgio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

Author keywords

Neuronal nitric oxide synthase; Osteoclastogenesis; RAW 264.7; Tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRAIN CRL 2278; CELL STRAIN RAW 264.7; CELL STRAIN TIB 71; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEMATOPOIETIC CELL; MACROPHAGE; METAPHASE; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

ACID PHOSPHATASE; ANIMALS; BONE RESORPTION; CARRIER PROTEINS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CLONE CELLS; ISOENZYMES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; NITRIC OXIDE SYNTHASE TYPE I; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

MURINAE;

EID: 26444529956     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.a.20239     Document Type: Article

References (24)

1. Aguirre J, Buttery L, O'Shaughnessy M, Afzal F, Fernandez DM, Hukkannen M, MacIntyre I, Polak J. 2001. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol 158:247-257.
2. Bab IA, Einhorn TA. 1994. Polypeptide factors regulating osteogenesis and bone marrow repair. J Cell Biochem 55:358-365.
3. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342
4. Brandi ML, Hukkanen M, Umeda T, Moradi-Bidhendi N, Bianchi S, Gross SS, Polak JM, MacIntyre I. 1995. Bidirectional regulation of osteoclast function by nitric oxide isoforms. Proc Natl Acad Sci USA 92:2954-2958.
5. Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Osdoby P. 2000. Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantonic membrane in association with neoangiogenesis. J Bone Miner Res 15:474-488.
6. Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M, Banovic T, Callon KE, Grey AB, Reid IR, Middleton-Hardie CA, Cornish J. 2002. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet 21:19-27.
7. Fox SW, Chow JW. 1998. Nitric oxide syntase expression in bone cells. Bone 23:1-6.
8. Helfrich MH, Evans DE, Grabowsky PS, Pollock JS, Oshima H, Ralston SH. 1997. Expression of nitric oxide syntase isoforms in bone and bone cell cultures. J Bone Miner Res 12:1108-1115.
9. Holliday LS, Dean AD, Lin RH, Greenwald JE, Gluck SL. 1997. NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am J Physiol 272:F283-F291.
10. Hukkanen M, Platts LA, Lawes T, Girgis SI, Konttinen YT, Goodship AE, MacIntyre I, Polak JM. 2003. Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone 32:142-149.
11. Jung JY, Lin AC, Ramos LM, Faddis BT, Choie RA. 2003. Nitric oxide syntase I mediated osteoclast activity in vitro and in vivo. J Cell Biochem 89:613-621.
12. Kasten TP, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko TP, Settle SL, Currie MG, Nickols GA. 1994. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 91:3569-3573.
13. Lee SE, Chung HB, Kwak CH, Chung KB, Kwack ZH. 2001. Tumor necrosis factor-alpha supports the survival of osteoclast through the activation of Akt and ERK. J Biol Chem 276:49343-49349.
14. Liu W, Xu D, Yang H, Xu H, Shi Z, Cao X, Takeshita S, Liu J, Teale M, Feng X. 2004. Functional identification of three receptor activator of NF-kappa B cytoplasmic motifs mediating osteoclast differentiation and function. J Biol Chem 279:54759-54769.
15. Lowik CW, Nibbering PH, van de Ruit M, Papapoulos SE. 1994. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest 93:1465-1472.
16. MacIntyre I, Zaidi M, Alam AS, Datta HK, Moonga BS, Lidbury PS, Hecker M, Vane JR. 1991. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 88: 2936-2940.
17. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N. 1995. Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res 10:1040-1049.
18. van't Hof RJ, Ralston SH. 1997. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J Bone Miner Res 12:1797-1804.
19. van't Hof RJ, Armour KJ, Smith LM, Armour KE, Wei XQ, Liew FY, Ralston SH. 2000. Requirement of the inducible nitric oxide pathway for IL-1-induced osteoclastic bone resorption. Proc Natl Acad Sci USA 97:7993-7998.
20. van't Hof RJ, Macphee J, Libouban H, Helfrich MH, Ralston SH. 2004. Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology 145:5068-5074.
21. Walsh MC, Choi Y. 2003. Biology of the TRANCE axis. Cytokine Growth Factor Rev 14:251-263.
22. Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, Shevde NK, Segal D, Dzivenu OK, Vologodskaia M, Yim M, Du K, Singh S, Pike JW, Darnay BG, Choi Y, Wu H. 2002. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 25:443-447.
23. Zauli G, Vitale M, Re MC, Furlini G, Zamai L, Falcieri E, Gibellini D, Visani G, Davis BR, Capitani S. 1994. In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line. Blood 83:167-175.
24. Zauli G, Rimondi E, Nicolin V, Melloni E, Celeghini C, Secchiero P. 2004. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. Blood 104: 2044-2050.